Your browser is no longer supported. Please, upgrade your browser.
Settings
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E76.38 EPS (ttm)2.14 Insider Own0.34% Shs Outstand37.47M Perf Week1.72%
Market Cap6.13B Forward P/E33.21 EPS next Y4.93 Insider Trans-9.91% Shs Float37.45M Perf Month7.95%
Income81.00M PEG5.19 EPS next Q1.29 Inst Own97.40% Short Float2.09% Perf Quarter10.61%
Sales619.30M P/S9.90 EPS this Y-27.50% Inst Trans-1.52% Short Ratio4.55 Perf Half Y28.12%
Book/sh28.22 P/B5.80 EPS next Y11.42% ROA7.40% Target Price158.43 Perf Year46.63%
Cash/sh4.71 P/C34.77 EPS next 5Y14.72% ROE11.80% 52W Range109.96 - 166.81 Perf YTD26.35%
Dividend1.28 P/FCF63.29 EPS past 5Y-7.70% ROI6.50% 52W High-2.45% Beta0.73
Dividend %0.78% Quick Ratio4.30 Sales past 5Y12.30% Gross Margin67.90% 52W Low47.98% ATR2.50
Employees1800 Current Ratio5.60 Sales Q/Q13.90% Oper. Margin20.00% RSI (14)65.47 Volatility1.52% 1.71%
OptionableYes Debt/Eq0.00 EPS Q/Q-12.50% Profit Margin18.80% Rel Volume0.84 Prev Close163.68
ShortableYes LT Debt/Eq0.37 EarningsMay 02 BMO Payout41.10% Avg Volume171.89K Price162.72
Recom1.80 SMA204.25% SMA506.53% SMA20018.13% Volume49,160 Change-0.59%
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Apr-18-08Downgrade Robert W. Baird Outperform → Neutral $71
Sep-07-07Downgrade Leerink Swann Outperform → Mkt Perform
Jan-31-07Downgrade First Analysis Sec Overweight → Equal-Weight
Jun-07-18 08:00AM  Bio-Techne To Acquire Quad Technologies PR Newswire
Jun-04-18 10:00AM  Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference PR Newswire
May-24-18 10:00AM  Bio-Techne To Present At The Jefferies 2018 Healthcare Conference PR Newswire
May-16-18 08:00AM  Better Know Biotech: 2 Stocks You Ought to Know About Motley Fool
May-10-18 10:00AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-07-18 02:19PM  When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)? Simply Wall St.
May-03-18 10:05PM  Edited Transcript of TECH earnings conference call or presentation 2-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-02-18 10:18AM  Does Bio-Techne Corporations (NASDAQ:TECH) PE Ratio Warrant A Sell? Simply Wall St.
07:00AM  Bio-Techne Releases Third Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
May-01-18 10:00AM  Bio-Techne To Present At The Deutsche Bank 43rd Annual Health Care Conference PR Newswire
Apr-26-18 01:00PM  Bio-Techne Leads the Way in Scientific Support for Autophagy Research PR Newswire
Apr-24-18 04:15PM  Bio-Techne Announces New Leadership Appointment PR Newswire
Apr-18-18 07:55AM  New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-29-18 07:45AM  New Research: Key Drivers of Growth for Bio-Techne, QTS Realty Trust, CYS Investments, Prologis, Gramercy Property Trust, and NanoString Technologies Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-22-18 08:44AM  3 Reasons Momentum Stock Investors Will Love Bio-Techne (TECH) Zacks
Mar-21-18 01:00PM  Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development PR Newswire
Mar-15-18 08:00AM  10 Growth Stocks for Long-Term Investors Investopedia
Mar-14-18 01:00PM  Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract PR Newswire
Feb-14-18 07:50AM  Blog Exposure - AVEO Announced Positive NICE Recommendation for FOTIVDA(R) as First Line Treatment for Advanced Renal Cell Carcinoma ACCESSWIRE
Feb-09-18 04:55AM  Edited Transcript of TECH earnings conference call or presentation 6-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
Feb-07-18 09:00AM  Bio-Techne Named "Researchers' Choice" by CiteAb PR Newswire
Feb-06-18 11:39AM  What does Bio-Techne Corporations (NASDAQ:TECH) Balance Sheet Tell Us About Its Future? Simply Wall St.
09:25AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Releases Second Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Feb-05-18 08:00AM  Bio-Techne To Present At The Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
Jan-30-18 05:11PM  Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms PR Newswire
Jan-26-18 07:40AM  Research Report Identifies Methode Electronics, Bio-Techne, VOXX International, American Tower Corporation (REIT), Medical Properties Trust, and HRG Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-24-18 07:02AM  The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Bio-Techne, Exelixis, Paratek and Bioverativ Zacks
Jan-18-18 07:30AM  Bio-Techne To Host Conference Call On February 6, 2018 To Announce Second Quarter 2018 Financial Results PR Newswire
Jan-15-18 09:00AM  Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne PR Newswire
08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Jan-02-18 05:01PM  Bio-Techne Acquires Atlanta Biologicals Inc. PR Newswire
Dec-28-17 08:00AM  Bio-Techne To Present At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-15-17 02:10PM  ETFs with exposure to Bio-Techne Corp. : December 15, 2017 Capital Cube
Nov-30-17 10:54AM  Edited Transcript of TECH earnings conference call or presentation 31-Oct-17 1:00pm GMT Thomson Reuters StreetEvents
Nov-28-17 08:30AM  Bio-Techne's RNAscope® Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-ranging Research with over 1000 Publications PR Newswire
Nov-27-17 03:54PM  ETFs with exposure to Bio-Techne Corp. : November 27, 2017 Capital Cube
Nov-20-17 07:30AM  Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design PR Newswire
Nov-17-17 01:02PM  ETFs with exposure to Bio-Techne Corp. : November 17, 2017 Capital Cube
Nov-16-17 09:03AM  Bio-Techne Corp. :TECH-US: Earnings Analysis: Q1, 2018 By the Numbers : November 16, 2017 Capital Cube
Nov-14-17 10:00AM  Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher PR Newswire
Nov-08-17 07:40AM  Featured Company News - Japanese Patent Office Issued New Patent to Alexion Pharma's Soliris; Extending Patent Protection into 2027 ACCESSWIRE
Nov-07-17 09:00AM  Women In Bio Announces that Alpna Seth Joins Bio-Technes Board of Directors GlobeNewswire
Nov-01-17 03:00AM  Bio-Techne Shows Market Leadership With Jump To 81 RS Rating Investor's Business Daily
Oct-31-17 07:35AM  Bio-Techne Releases First Quarter Fiscal 2018 Results PR Newswire +5.99%
07:35AM  Bio-Techne Declares Dividend PR Newswire
07:30AM  Bio-Techne to Host Earnings Call ACCESSWIRE
Oct-30-17 12:18PM  ETFs with exposure to Bio-Techne Corp. : October 30, 2017 Capital Cube
08:48AM  Is a Surprise Coming for Bio-Techne (TECH) This Earnings Season? Zacks
Oct-27-17 09:00AM  Bio-Techne To Present At The Stephens Fall Investment Conference PR Newswire
Oct-26-17 05:00PM  Bio-Techne Adds Two New Directors to Its Board PR Newswire
Oct-16-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Oct-13-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Oct-11-17 07:30AM  Bio-Techne To Host Conference Call On October 31, 2017 To Announce First Quarter 2018 Financial Results PR Newswire
Oct-10-17 11:50AM  ETFs with exposure to Bio-Techne Corp. : October 10, 2017 Capital Cube
Oct-09-17 09:54AM  Bio-Techne Corp. :TECH-US: Earnings Analysis: Q4, 2017 By the Numbers : October 9, 2017 Capital Cube
Oct-05-17 07:30AM  Joint Consortia Framework Awards Contract to Bio-Techne as Supplier of Research Antibodies PR Newswire
Oct-04-17 08:07AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Oct-03-17 03:00AM  Bio-Techne Shows Rising Relative Strength; Still Shy Of Key Benchmark Investor's Business Daily
Sep-28-17 10:56AM  Bio-Techne's New Simple Plex Cartridge Boosts Protein Segment Zacks
Sep-21-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Sep-20-17 07:30AM  Bio-Techne Unveils a New Multi-Analyte Cartridge Format for the Ella Immunoassay Platform, Improving Sample Throughput PR Newswire
Sep-15-17 08:04AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Sep-14-17 08:04AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Sep-13-17 09:05PM  ETFs with exposure to Bio-Techne Corp. : September 14, 2017 Capital Cube
07:30AM  Bio-Techne Introduces a New Luminex Multi-analyte Assay Kit PR Newswire
Sep-11-17 05:28PM  Bio-Techne Corp. :TECH-US: Earnings Analysis: 2017 By the Numbers : September 11, 2017 Capital Cube
Sep-08-17 07:30AM  Featured Company News - Bio-Techne Acquires Trevigen in an All-cash Deal ACCESSWIRE
Sep-06-17 05:39PM  Bio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections PR Newswire
Sep-05-17 06:06PM  Bio-Techne Acquires Trevigen Inc. PR Newswire
Sep-02-17 08:10AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Aug-30-17 03:42PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Techne Corporation - TECH PR Newswire
Aug-28-17 07:30AM  Bio-Techne To Present At The Wells Fargo Healthcare Conference PR Newswire
Aug-22-17 07:30AM  Bio-Techne To Present At The Baird 2017 Global Healthcare Conference PR Newswire
Aug-18-17 09:05PM  Bio-Techne Corp. Value Analysis (NASDAQ:TECH) : August 19, 2017 Capital Cube
11:21AM  Google's Alphabet passes Facebook as hedge fund favorite Yahoo Finance Video
07:40AM  Corporate News Blog - Exelixis Submits US Supplemental New Drug Application for CABOMETYX(R) for the Treatment of Previously Untreated Advanced Kidney Cancer ACCESSWIRE
Aug-16-17 10:25AM  Edited Transcript of TECH earnings conference call or presentation 8-Aug-17 1:00pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Aug-12-17 08:05AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Aug-10-17 05:00PM  Bio-Techne Declares Dividend PR Newswire
09:52AM  Bio-Techne (TECH) Beats Earnings, Revenue Estimates in Q4 Zacks
Aug-09-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Aug-08-17 08:28AM  Bio-Techne Corp. breached its 50 day moving average in a Bullish Manner : TECH-US : August 8, 2017 Capital Cube
07:30AM  Bio-Techne Releases Fourth Quarter Fiscal 2017 Results PR Newswire
06:10AM  Investor Network: Bio-Techne to Host Earnings Call ACCESSWIRE
Aug-04-17 08:39AM  Should You Buy Bio-Techne (TECH) Ahead of Earnings? Zacks
Aug-01-17 05:22PM  ETFs with exposure to Bio-Techne Corp. : August 1, 2017 Capital Cube
Jul-13-17 04:43PM  ETFs with exposure to Bio-Techne Corp. : July 13, 2017 Capital Cube
Jul-12-17 08:30AM  Bio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial Results PR Newswire
Jul-03-17 03:53PM  ETFs with exposure to Bio-Techne Corp. : July 3, 2017 Capital Cube
Jun-19-17 04:10PM  ETFs with exposure to Bio-Techne Corp. : June 19, 2017 Capital Cube
Jun-16-17 09:32AM  Bio-Techne Corp. :TECH-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-01-17 09:53AM  How Washington is throwing away its shot at protecting your privacy Yahoo Finance
May-24-17 08:00AM  Bio-Techne To Present At The Jefferies 2017 Global Healthcare Conference PR Newswire
May-23-17 03:05PM  Edited Transcript of TECH earnings conference call or presentation 2-May-17 1:00pm GMT Thomson Reuters StreetEvents
May-18-17 11:47AM  Bio-Techne Corp. : TECH-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers : May 18, 2017 Capital Cube
May-08-17 07:30AM  Bio-Techne To Present At The Bank Of America Merrill Lynch Health Care Conference PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates through three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization assays for the research and clinical diagnostics markets. It also provides various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, including cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Protein Platforms segment develops, manufactures, and sells tools, such as Biologics platform that enables researchers interrogate protein purity and identify contaminants during the development and production of biologics; Simple Western platform for protein analysis and identification; SimplePlex platform, an enzyme-linked immunosorbent assay for use in research and clinical diagnostics; and Single Cell Western platform to elucidate the properties of individual cells to understand cell behavior. The Diagnostics segment offers controls and calibrators for hematology clinical instruments; blood chemistry and blood gas quality controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market; bulk purified proteins, enzymes, disease-state plasmas, infectious disease antigens, and processed serums to the clinical diagnostic industry; and Paratest, a novel and convenient stool collection and test device for the veterinary market. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kummeth Charles R.Chief Executive OfficerJun 07Sale160.008,0001,280,00076,472Jun 08 04:21 PM
Eansor Norman DavidSVP - Novus BiologicalsMay 04Sale145.191,136164,9322,266May 11 04:16 PM
Dinarello Charles ADirectorFeb 13Option Exercise65.475,000327,35013,212Feb 15 04:02 PM
Dinarello Charles ADirectorFeb 13Sale136.065,000680,3038,212Feb 15 04:02 PM
BAUMGARTNER ROBERT VDirectorNov 01Option Exercise63.035,000315,15012,712Nov 03 04:41 PM
BAUMGARTNER ROBERT VDirectorNov 01Sale130.185,000650,9077,712Nov 03 04:41 PM
LUCAS ROGER CDirectorOct 10Sale121.9610012,1961,870Oct 12 04:24 PM
LUCAS ROGER CDirectorSep 08Sale120.9410012,0941,970Sep 12 05:02 PM
HOLBROOK KAREN ADirectorSep 06Sale121.731,059128,909914Sep 08 04:44 PM
LUCAS ROGER CDirectorAug 10Sale114.3010011,4302,070Aug 14 04:24 PM
LUCAS ROGER CDirectorJul 10Sale116.8610011,6862,170Jul 12 04:34 PM